<- Go Home
Novartis India Limited
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.
Market Cap
INR 25.6B
Volume
10.0K
Cash and Equivalents
N/A
EBITDA
INR 909.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 1.5B
Profit Margin
43.77%
52 Week High
INR 1.1K
52 Week Low
INR 750.00
Dividend
2.41%
Price / Book Value
3.31
Price / Earnings
26.36
Price / Tangible Book Value
3.31
Enterprise Value
INR 19.5B
Enterprise Value / EBITDA
21.05
Operating Income
INR 902.2M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
INR 6.2B
Debt
INR 40.5M
Equity
INR 7.8B
Revenue
INR 3.5B
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A